Casey Fowler considers how intellectual property (IP) management will play a role in protecting pharma companies’ investments and future R&D. Protecting the process Intellectual property (IP ...
The current model means all interested stakeholders can have a say in IP address management, not just the private sector.” NRO acknowledges that: “Public sector participation in ICANN, particularly as ...